Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.01% slid 1.96% to $161.98 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.54% falling 1.31% to 4,166.45 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.42% falling 1.58% to 33,290.08. Johnson & Johnson closed $11.67 below its 52-week high ($173.65), which the company achieved on January 26th.
The stock underperformed when compared to some of its competitors Friday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF +1.79% fell 0.03% to $375.90, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -0.08% fell 0.80% to $76.61, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +0.05% fell 1.70% to $38.81. Trading volume (12.7 M) eclipsed its 50-day average volume of 7.1 M.